Biolaser ApS: Financial statements 2021
CVR: 21333271
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Biolaser ApS (CVR 21333271) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 317,504 and a net result of DKK 247,670 compared with DKK -169,120 the year before. Equity in the 2021 report amounted to DKK 1,115,959. The solvency ratio was 77.5%.
- Gross Profit
- DKK 317,504
- Profit/Loss
- DKK 247,670
- Equity
- DKK 1,115,959
- Total Assets
- DKK 1,439,900
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 318 t. | 248 t. | 1.1 mio. | 0 |
| 2020 | - | -10 t. | -169 t. | 1 mio. | 1 |
| 2019 | - | 593 t. | 316 t. | 1.2 mio. | 1 |
| 2018 | - | 288 t. | 223 t. | 872 t. | 0 |
| 2017 | - | 119 t. | 92 t. | 649 t. | - |
Official annual report
Find more companies like Biolaser ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Biolaser ApS has published its annual report for 2020. Gross profit came to DKK -10,383, and the net result was DKK -169,120.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.